Neste vídeo, vamos explorar o emocionante novo "Among Us" de 2021! Descubra comigo as atualizações e novidades que este jogo de estratégia e mistério trouxe este ano. Testaremos juntos as novas ...

A pill form of weight-loss drug Wegovy, manufactured by Danish drugmaker Novo Nordisk, is now available in the U.S., giving Americans access to an oral medication to treat obesity. The starting dose ...

Dec 23 (Reuters) - Novo Nordisk shares jumped ‌10% on Tuesday after the U.S. Food and ‌Drug Administration approved its weight-loss pill, giving the Danish drugmaker a competitive edge over rival Eli ...

Add Yahoo as a preferred source to see more of our stories on Google. FILE PHOTO: The logo of pharmaceutical company Novo Nordisk is displayed in front of its offices in Bagsvaerd, on the outskirts of ...

CHONGQING, CHINA - SEPTEMBER 10: In this photo illustration, the logo of Novo Nordisk is displayed on a smartphone screen on September 10, 2025 in Chongqing, China. The maker of Wegovy and Ozempic, ...

Septerna, Inc. delivered a strong 3Q25, driven by partnership revenue from its transformative collaboration with Novo Nordisk. SEPN's Novo partnership brings $195M upfront, a potential $2.2B in ...

--Down 48.34% year-to-date; on pace for worst year since 1984, when it fell 57.59% --Down 69.75% from its all-time closing high of $146.91 on June 25, 2024 --Down 57.50% from 52 weeks ago (Nov. 25, ...

Denmark's seasonally adjusted gross domestic product grew by 2.3% in the third quarter, a preliminary reading from Statistics Denmark showed early Thursday. The main driver of growth was the ...

Novo Nordisk NOVO.B3.56%increase; green up pointing triangle shareholders approved the appointment of Lars Rebien Sorensen as new chair as part of a broader move to shake up the company’s board of ...

Novo shares rise 2.5% after exiting Metsera bidding war Norway's wealth fund abstains from Novo board vote, citing governance concerns Analysts warn foundation's control push may increase instability ...

Amid Novo Nordisk and Pfizer’s whiplash contest for obesity biotech Metsera, Novo’s CEO has, quite literally, told his company's rival to put its money where its mouth is. “Novo Nordisk and Pfizer ...